COVID-19 Balancing the Need of Public Health and the Economy

No.22/2023

$0.00

Download Now
As nations advance innovation and technology across various fields—particularly in the medical sector—success in medical breakthroughs has not been without its challenges. Countries leading research in medical innovations have, at times, crossed regulatory boundaries in their pursuit of becoming pioneers. This ambition has driven some nations to prioritize innovation over compliance, often at the expense of established laws.

Description

As nations advance innovation and technology across various fields—particularly in the medical sector—success in medical breakthroughs has not been without its challenges. Countries leading research in medical innovations have, at times, crossed regulatory boundaries in their pursuit of becoming pioneers. This ambition has driven some nations to prioritize innovation over compliance, often at the expense of established laws.
International health regulatory consortia have been sidelined in the process, leading to significant risks. The exposure of biohazard materials poses a threat to human health, endangering the human species and raising critical concerns about ethical and regulatory oversight in medical innovation.

Reviews

There are no reviews yet.